Bank of New York Mellon’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bank of New York Mellon’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-16,178	Closed	-$108K	–	4372
2015 Q4	$108K	Hold	16,178	–	–	﹤0.01%	4042
2015 Q3	$81K	Buy	+16,178	New	+$86.9K	﹤0.01%	4164
2015 Q2	–	Sell	-27,013	Closed	-$283K	–	4371
2015 Q1	$283K	Buy	27,013 +1,220	+5%	+$12.6K	﹤0.01%	3798
2014 Q4	$325K	Sell	25,793 -87	-0.3%	-$1.19K	﹤0.01%	3759
2014 Q3	$374K	Sell	25,880 -40	-0.2%	-$581	﹤0.01%	3715
2014 Q2	$404K	Buy	+25,920	New	+$393K	﹤0.01%	3664

Bank of New York Mellon's TRIV Position: Q1 2016 in Review

Bank of New York Mellon sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 16,178 shares — an estimated $108K sold.

Bank of New York Mellon first reported a position in TRIV in Q2 2014 and held it in 6 quarters. The position peaked at $404K in Q2 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Bank of New York Mellon reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Bank of New York Mellon sold 16,178 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $108K.
Bank of New York Mellon first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 6 quarters.
Bank of New York Mellon's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $404K in Q2 2014.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Bank of New York Mellon's 13F filing for Q1 2016, filed 11 May 2016.